根据国际疾病分类（ICD）和精神疾病诊断与统计手册第三版（DSM-III）分类系统，地塞米松抑制试验在抑郁症中的表现。

Performance of the dexamethasone suppression test in depressive illness according to ICD and DSM-III classification systems.

作者信息

Watkins S, Harris B, Cook N, Thomas R, Riad-Fahmy D

机构信息

Pen-y-fai Hospital, Bridgend.

出版信息

Br J Psychiatry. 1988 Apr;152:554-8. doi: 10.1192/bjp.152.4.554.

DOI:10.1192/bjp.152.4.554

PMID:3167410

Abstract

The performance of the dexamethasone suppression test was assessed in 90 consecutive admissions with a diagnosis of depression, categorised according to two classification systems (DSM-III and ICD-9). Non-suppression was found in most of the diagnostic categories, but there was a highly significant association with the DSM-III classification 'major depressive episode with melancholia' (52%) in comparison with the ICD group 'manic-depressive illness-depressed' (29%).

摘要

对90例连续入院诊断为抑郁症的患者进行了地塞米松抑制试验，根据两种分类系统（DSM-III和ICD-9）进行分类。在大多数诊断类别中均发现了非抑制现象，但与ICD组“躁郁症-抑郁型”（29%）相比，“伴有忧郁症的重度抑郁发作”这一DSM-III分类存在高度显著关联（52%）。